PROPANC BIOPHARMA, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number
PROPANC BIOPHARMA, INC. (PPCB) had Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number of 11.01 thousand shares as of 2026-03-31, per its S-1 filed 2026-07-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber · last filed 2026-07-17
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 11.01K shares; Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed 40.05K shares.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 40.15K shares.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 30.25K shares.
- 2025-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number 10.00 shares; Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed 250.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding, Number as first filed |
|---|---|---|
| 2026-03-31 | 11.01K shares S-1 · filed 2026-07-17 | 40.05K shares 10-Q · filed 2026-05-14 |
| 2025-12-31 | 40.15K shares S-1 · filed 2026-04-10 | |
| 2025-09-30 | 30.25K shares 10-Q · filed 2025-11-14 | |
| 2025-06-30 | 10.00 shares S-1 · filed 2026-07-17 | 250.00 shares 10-K · filed 2025-09-29 |
| 2025-03-31 | 250.00 shares 10-Q · filed 2025-05-15 | |
| 2024-12-31 | 250.00 shares 10-Q · filed 2025-02-14 | |
| 2024-09-30 | 15.00M shares 10-Q · filed 2024-11-14 | |
| 2024-06-30 | 10.00 shares S-1 · filed 2026-07-17 | 15.00M shares 10-K · filed 2024-09-30 |
| 2024-03-31 | 15.00M shares 10-Q · filed 2024-05-15 | |
| 2023-12-31 | 15.00M shares 10-Q · filed 2024-02-20 | |
| 2023-09-30 | 15.00M shares 10-Q · filed 2023-11-14 | |
| 2023-06-30 | 0.06 shares S-1 · filed 2026-04-10 | 3.40K shares 10-K · filed 2023-09-28 |
| 2023-03-31 | 3.40M shares 10-Q · filed 2023-05-15 | |
| 2022-12-31 | 3.40M shares 10-Q · filed 2023-02-10 | |
| 2022-09-30 | 3.41M shares 10-Q · filed 2022-11-14 | |
| 2022-06-30 | 105.00 shares 10-K · filed 2024-09-30 | 105.42K shares 10-K · filed 2022-09-28 |
| 2022-03-31 | 109.36K shares 10-Q · filed 2022-05-16 | |
| 2021-12-31 | 111.91K shares 10-Q · filed 2022-02-14 | |
| 2021-09-30 | 111.93K shares 10-Q · filed 2021-11-12 | |
| 2021-06-30 | 121.00 shares 10-K · filed 2023-09-28 | 121.33K shares 10-K · filed 2021-09-28 |
| 2021-03-31 | 127.59K shares 10-Q · filed 2021-05-14 | |
| 2020-12-31 | 135.72K shares 10-Q · filed 2021-02-12 | |
| 2020-09-30 | 135.72M shares 10-Q · filed 2020-11-16 | |
| 2020-06-30 | 151.17K shares 10-K · filed 2022-09-28 | 151.17M shares 10-K · filed 2020-10-01 |
| 2019-06-30 | 59.00 shares 10-K · filed 2020-10-01 | |
| 2018-06-30 | 291.00 shares 10-K · filed 2020-10-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |